Literature DB >> 20946934

Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis.

Ranjan Dutta1, Bruce D Trapp.   

Abstract

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system. Due to its high prevalence, MS is the leading cause of non-traumatic neurological disability in young adults in the United States and Europe. The clinical disease course is variable and starts with reversible episodes of neurological disability in the third or fourth decade of life. This transforms into a disease of continuous and irreversible neurological decline by the sixth or seventh decade. Available therapies for MS patients have little benefit for patients who enter this irreversible phase of the disease. It is well established that irreversible loss of axons and neurons are the major cause of the irreversible and progressive neurological decline that most MS patients endure. This review discusses the etiology, mechanisms and progress made in determining the cause of axonal and neuronal loss in MS.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20946934      PMCID: PMC3030928          DOI: 10.1016/j.pneurobio.2010.09.005

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  164 in total

1.  Axonal changes in chronic demyelinated cervical spinal cord plaques.

Authors:  G Lovas; N Szilágyi; K Majtényi; M Palkovits; S Komoly
Journal:  Brain       Date:  2000-02       Impact factor: 13.501

Review 2.  Multiple sclerosis.

Authors:  J H Noseworthy; C Lucchinetti; M Rodriguez; B G Weinshenker
Journal:  N Engl J Med       Date:  2000-09-28       Impact factor: 91.245

Review 3.  [The evidence for primary axonal loss in multiple sclerosis].

Authors:  D C Anthony; P Hughes; V H Perry
Journal:  Rev Neurol       Date:  2000 Jun 16-30       Impact factor: 0.870

4.  Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation.

Authors:  A Bitsch; J Schuchardt; S Bunkowski; T Kuhlmann; W Brück
Journal:  Brain       Date:  2000-06       Impact factor: 13.501

Review 5.  Proton MR spectroscopy to assess axonal damage in multiple sclerosis and other white matter disorders.

Authors:  N De Stefano; S Narayanan; P M Matthews; M Mortilla; M T Dotti; A Federico; D L Arnold
Journal:  J Neurovirol       Date:  2000-05       Impact factor: 2.643

6.  Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

7.  Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis.

Authors:  H Reddy; S Narayanan; R Arnoutelis; M Jenkinson; J Antel; P M Matthews; D L Arnold
Journal:  Brain       Date:  2000-11       Impact factor: 13.501

8.  Changes in activated T cells in the blood correlate with disease activity in multiple sclerosis.

Authors:  S J Khoury; C R Guttmann; E J Orav; R Kikinis; F A Jolesz; H L Weiner
Journal:  Arch Neurol       Date:  2000-08

9.  Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.

Authors:  B Kornek; M K Storch; R Weissert; E Wallstroem; A Stefferl; T Olsson; C Linington; M Schmidbauer; H Lassmann
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

10.  Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction.

Authors:  H Babbe; A Roers; A Waisman; H Lassmann; N Goebels; R Hohlfeld; M Friese; R Schröder; M Deckert; S Schmidt; R Ravid; K Rajewsky
Journal:  J Exp Med       Date:  2000-08-07       Impact factor: 14.307

View more
  137 in total

Review 1.  Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis.

Authors:  Kelly A Chamberlain; Sonia E Nanescu; Konstantina Psachoulia; Jeffrey K Huang
Journal:  Neuropharmacology       Date:  2015-10-22       Impact factor: 5.250

2.  Functional Expression of Electron Transport Chain and FoF1-ATP Synthase in Optic Nerve Myelin Sheath.

Authors:  Martina Bartolucci; Silvia Ravera; Greta Garbarino; Paola Ramoino; Sara Ferrando; Daniela Calzia; Simona Candiani; Alessandro Morelli; Isabella Panfoli
Journal:  Neurochem Res       Date:  2015-09-03       Impact factor: 3.996

3.  Noninvasive Quantification of Axonal Loss in the Presence of Tissue Swelling in Traumatic Spinal Cord Injury Mice.

Authors:  Tsen-Hsuan Lin; Peng Sun; Mitchell Hallman; Fay C Hwang; Michael Wallendorf; Wilson Z Ray; William M Spees; Sheng-Kwei Song
Journal:  J Neurotrauma       Date:  2019-01-11       Impact factor: 5.269

Review 4.  Pathogenic implications of iron accumulation in multiple sclerosis.

Authors:  Rachel Williams; Cassandra L Buchheit; Nancy E J Berman; Steven M LeVine
Journal:  J Neurochem       Date:  2011-11-11       Impact factor: 5.372

5.  Contactin-1 regulates myelination and nodal/paranodal domain organization in the central nervous system.

Authors:  Gülsen Çolakoğlu; Ulrika Bergstrom-Tyrberg; Erik O Berglund; Barbara Ranscht
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-02       Impact factor: 11.205

6.  Low-level laser therapy (810 nm) protects primary cortical neurons against excitotoxicity in vitro.

Authors:  Ying-Ying Huang; Kazuya Nagata; Clark E Tedford; Michael R Hamblin
Journal:  J Biophotonics       Date:  2013-10-15       Impact factor: 3.207

Review 7.  Systematic approaches to central nervous system myelin.

Authors:  Patricia de Monasterio-Schrader; Olaf Jahn; Stefan Tenzer; Sven P Wichert; Julia Patzig; Hauke B Werner
Journal:  Cell Mol Life Sci       Date:  2012-03-23       Impact factor: 9.261

Review 8.  Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis.

Authors:  Insha Zahoor; Shailendra Giri
Journal:  Clin Rev Allergy Immunol       Date:  2021-04       Impact factor: 8.667

9.  The impact of gradient strength on in vivo diffusion MRI estimates of axon diameter.

Authors:  Susie Y Huang; Aapo Nummenmaa; Thomas Witzel; Tanguy Duval; Julien Cohen-Adad; Lawrence L Wald; Jennifer A McNab
Journal:  Neuroimage       Date:  2014-12-09       Impact factor: 6.556

10.  Fibroblast growth factor signaling in oligodendrocyte-lineage cells facilitates recovery of chronically demyelinated lesions but is redundant in acute lesions.

Authors:  Miki Furusho; Aude J Roulois; Robin J M Franklin; Rashmi Bansal
Journal:  Glia       Date:  2015-04-22       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.